Answers are grounded in this paper and cite their sources.
Raman spectroscopy is a novel technology that enables real-time assessment of tissue biomolecular alterations correlated with histopathologic changes. We prospectively evaluated SPECTRA IMDx, a fiber-optic Raman spectroscopy–AI system, for the in vivo diagnosis of high-risk gastric neoplasia. In this two-center study, 198 patients with 238 gastric lesions underwent routine white-light endoscopy (WLE) followed by SPECTRA IMDx assessment, with histopathology serving as the reference standard. In the full cohort, SPECTRA IMDx showed higher sensitivity (90.0% vs. 58.0%), specificity (81.4% vs. 58.5%), and accuracy (83.2% vs. 58.4%) than routine WLE (all P < 0.001). Of particular clinical relevance, in the paired analysis of 131 lesions, SPECTRA IMDx and WLE + BLI each achieved 79.4% accuracy. Sensitivity was 88.5% versus 80.8%, specificity 77.1% versus 79.0%, and NPV 96.4% versus 94.3%, respectively; paired comparisons of accuracy, sensitivity, and specificity were not statistically significant. These findings warrant further evaluation of automated Raman-based lesion characterization and its potential added value alongside image-enhanced endoscopy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: